FIELD: medicine. SUBSTANCE: the suggested method for increasing antigenicity and/or immunogenicity of biomaterial deals with affecting it with laser radiation at wave length of 9-11 mcm and power density of 0.1-1 kW/sq. cm. Moreover, biomaterial is represented by either recombinant or synthetic proteins, or cellular membranes, or viruses, or bacteria, or chlamydia, or normal mature human cells, or embryonal cells. The present innovation, also, deals with increasing antigenicity and/or immunogenicity of biomaterial due to its physical modification in vivo by laser radiation for epidermic cells. EFFECT: more simplified method. 16 cl, 2 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| LASER VACCINATION METHOD FOR PATIENTS SUFFERING FROM METASTATIC CANCER TYPE | 2005 |
|
RU2345788C2 |
| PROTEIN-PEPTIDE ANTITUMOR COMPOSITION, CELL PREPARATION ACTIVATED THEREWITH AND METHOD FOR TUMOR PROPHYLAXIS OR TREATMENT | 2004 |
|
RU2283129C1 |
| STIMULATION OF IMMUNE RESPONSE BY ENANTIOMERS OF CATIONIC LIPIDS | 2009 |
|
RU2530555C2 |
| MICROORGANISMS AS CARRIERS OF NUCLEOTIDE SEQUENCES ENCODING CELLULAR ANTIGENS FOR TREATMENT OF TUMORS | 2003 |
|
RU2319741C2 |
| VACCINE COMPOSITIONS, METHODS FOR APPLICATION THEREOF IN MELANOMA PREVENTION AND TREATMENT, AND GENETIC CONSTRUCTIONS FOR OBTAINING ACTIVE SUBSTANCES OF COMPOSITION | 2006 |
|
RU2333767C2 |
| T-CELLS WITH TRANSDUCED ANTIGEN APPLIED AS ANTIGEN DELIVERY SYSTEMS | 2003 |
|
RU2330884C2 |
| IMMUNOPROPHYLACTIC CANCER VACCINE | 2004 |
|
RU2556128C2 |
| METHOD FOR STIMULATING PRESENTING ACTIVITY OF DENDRITIC CELLS | 2019 |
|
RU2728592C1 |
| PREVENTIVE CANCER VACCINE | 2004 |
|
RU2385163C2 |
| BIOMARKER FOR SELECTING PATIENTS AND RESPECTIVE QUESTIONS | 2009 |
|
RU2517719C2 |
